IDIOPATHIC PULMONARY FIBROSIS MARKET ANALYSIS

Regional Analysis

Global Idiopathic Pulmonary Fibrosis Market- Regional Analysis

Among region, North America is expected to dominate the market over the forecast period, owing to North America's 37.8% market share, and increasing cases of idiopathic pulmonary fibrosis in the U.S. For instance, in December 2020, according to the American IPF Foundation, the incidence of idiopathic pulmonary fibrosis (IPF) has doubled in the last ten years (2010-2020). In the U.S., approximately 50,000 people die from IPF every year that is higher than the death rate from breast cancer.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa